Basel Medical Group Ltd, a Singapore‑based healthcare provider listed on NASDAQ under the ticker BMGL, signed a purchase agreement to acquire up to 10,000 Bitcoin, totaling approximately US $1 billion—by issuing ordinary shares in exchange with a consortium of Bitcoin holders.
Company management stated the acquisition aims to diversify its treasury reserves significantly, reinforce its balance sheet, and fund ambitious expansion plans in high‑growth healthcare markets across the Asia‑Pacific.
The proposed transaction will be structured as a share‑swap model rather than a cash purchase, allowing Basel Medical to preserve liquidity for its core medical business while deploying capital efficiently.
Market reaction was swift—BMGL shares fell roughly 15 percent on May 16 after the announcement, reflecting investor concerns over exposure to Bitcoin’s volatility and dilution risk.
Analysts note the move places Basel Medical among a growing group of corporations expanding into cryptocurrency treasury strategy.
The company called the initiative a “landmark transaction” and expects to finalize the deal within the current quarter, subject to regulatory approvals.
BitcoinVersus.Tech Editor’s Note:
We volunteer daily to ensure the credibility of the information on this platform is Verifiably True. If you would like to support to help further secure the integrity of our research initiatives, please donate here
BitcoinVersus.tech is not a financial advisor. This media platform reports on financial subjects purely for informational purposes.
Bitcoin Versus 
Leave a comment